 |
diazepam (intranasal) |
|---|---|
| Trade Name | |
| Orphan Indication | Management of acute repetitive seizures |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-16 00:00:00 |
| Sponsor | Neurelis Pharmaceuticals, Inc.;1042-B N. El Camino Real, Suite 430;Encinitas, California, 92024 |
